Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-74.50	6.66	26.10
Graham Fair Price	41.50	0.10	0.07
PEG	-39.22	-0.16	0.27
Price/Book	8.98	0.45	0.41
Price/Cash Flow	-45.51	5.89	10.80
Prices/Earnings	45.51	-16.40	-30.11
Price/Sales	-45.51	0.46	0.85
Price/FCF	-45.51	5.89	10.80
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1.16	0.47	0.47
Operating Margin	6.57	0.07	0.06
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	-0.02	-130.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.16	-0.17	-1.58
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-0.48	1.13	138.01
EPS QOQ	-1.12	-1.00	10.34
FCF QOQ	2.80	1.00	-64.26
Revenue QOQ	-0.47	1.00	111.07
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.31	3.62	-50.52
Days Sales Outstanding (DSO)	68.32	43.80	-35.90
Inventory Turnover	12.31	24.87	102.10
Debt/Capitalization	0.40	0.35	-12.11
Quick Ratio	0.91	1.08	19.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.26	0.26	0.06
Cash	0.05	0.05	0.06
Capex	< 0.005	-0.02	-449.33
Free Cash Flow	< 0.005	0.02	100.11
Revenue	0.13	0.25	100.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.17	1.17	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.17	3.80	-73.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating